Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HUMAN-LIVER-MICROSOMES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1416 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Huitema, ADR; Mathot, RAA; Tibben, MM; Rodenhuis, S; Beijnen, JH
      A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide

      JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
    2. Van Vleet, TR; Klein, PJ; Coulombe, RA
      Metabolism of aflatoxin B-1 by normal human bronchial epithelial cells

      JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A
    3. Cole, CE; Tran, HT; Schlosser, PM
      Physiologically based pharmacokinetic modeling of benzene metabolism in mice through extrapolation from in vitro to in vivo

      JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A
    4. Ho, PC; Saville, DJ; Wanwimolruk, S
      Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds

      JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
    5. Mehvar, R; Brocks, DR
      Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans

      JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
    6. Ellis, E; Roeb, E; Marschall, HU
      Primary cultures of human hepatocytes but not HepG2 hepatoblastoma cells are suitable for the study of glycosidic conjugation of bile acids

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    7. Peng, SX
      Separation and identification methods for metalloproteinase inhibitors

      JOURNAL OF CHROMATOGRAPHY B
    8. Baumann, F; Preiss, R
      Cyclophosphamide and related anticancer drugs

      JOURNAL OF CHROMATOGRAPHY B
    9. Ohman, D; Carlsson, B; Norlander, B
      On-line extraction using an alkyl-diol silica precolumn for racemic citalopram and its metabolites in plasma - Results compared with solid-phase extraction methodology

      JOURNAL OF CHROMATOGRAPHY B
    10. Masimirembwa, CM; Thompson, R; Andersson, TB
      In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery

      COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
    11. Fujita, K; Kamataki, T
      Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    12. Muto, S; Fujita, K; Yamazaki, Y; Kamataki, T
      Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    13. Guengerich, FP
      Forging the links between metabolism and carcinogenesis

      MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
    14. Heo, MY; Sohn, SJ; Au, WW
      Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate

      MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
    15. Rodrigues, AD; Lin, JH
      Screening of drug candidates for their drug-drug interaction potential

      CURRENT OPINION IN CHEMICAL BIOLOGY
    16. Giembycz, MA
      Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    17. Wellington, K; Perry, CM
      Venlafaxine extended-release - A review of its use in the management of major depression

      CNS DRUGS
    18. Solai, LKK; Mulsant, BH; Pollock, BG
      Selective serotonin reuptake inhibitors for late-life depression - A comparative review

      DRUGS & AGING
    19. Hiratsuka, M; Mizugaki, M
      Genetic polymorphisms in drug-metabolizing enzymes and drug targets

      MOLECULAR GENETICS AND METABOLISM
    20. Van Vleet, TR; Bombick, DW; Coulombe, RA
      Inhibition of human cytochrome P450 2E1 by nicotine, cotinine, and aqueouscigarette tar extract in vitro

      TOXICOLOGICAL SCIENCES
    21. Licata, AC; Dekant, W; Smith, CE; Borghoff, SJ
      A physiologically based pharmacokinetic model for methyl tert-butyl ether in humans: Implementing sensitivity and variability analyses

      TOXICOLOGICAL SCIENCES
    22. Delaporte, E; Slaughter, DE; Egan, MA; Gatto, GJ; Santos, A; Shelley, J; Price, E; Howells, L; Dean, DC; Rodrigues, AD
      The potential for CYP2D6 inhibition screening using a novel scintillation proximity assay-based approach

      JOURNAL OF BIOMOLECULAR SCREENING
    23. Kariv, I; Fereshteh, MP; Oldenburg, KR
      Development of a miniaturized 384-well high throughput screen for the detection of substrates of cytochrome P-450 2D6 and 3A4 metabolism

      JOURNAL OF BIOMOLECULAR SCREENING
    24. Kang, MH; Figg, WD; Ando, Y; Blagosklonny, MV; Liewehr, D; Fojo, T; Bates, SE
      The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6 alpha-hydroxypaclitaxel, a major metabolite of paclitaxel

      CLINICAL CANCER RESEARCH
    25. Wienkers, LC
      Problems associated with in vitro assessment of drug inhibition of CYP3A4 and other P-450 enzymes and its impact on drug discovery

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    26. Moolchan, ET; Umbricht, A; Epstein, D
      Therapeutic drug monitoring in methadone maintenance: Choosing a matrix

      JOURNAL OF ADDICTIVE DISEASES
    27. Smith, G; Sachse, C
      A role for CYP2D6 in nicotine metabolism? Target article on nicotine-addiction

      PSYCOLOQUY
    28. Oscarson, M
      Nicotine metabolism by the polymorphic cytochrome P450 2A6 (CYP2A6) enzyme: Implications for interindividual differences in smoking behaviour target article on nicotine-addiction

      PSYCOLOQUY
    29. Rojas, VM; Silva, R
      Palpebral twitching in a depressed adolescent on citalopram

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    30. Lovern, MR; Cole, CE; Schlosser, PM
      A review of quantitative studies of benzene metabolism

      CRITICAL REVIEWS IN TOXICOLOGY
    31. Bessems, JGM; Vermeulen, NPE
      Paracetamol (acetaminophen)-induced toxicity: Molecular and biochemical mechanisms, analogues and protective approaches

      CRITICAL REVIEWS IN TOXICOLOGY
    32. Radominska-Pandya, A; Chen, GP; Samokyszyn, VM; Little, JM; Gall, WE; Zawada, G; Terrier, N; Magdalou, J; Czernik, P
      Application of photoaffinity labeling with [H-3] all trans- and 9-cis-retinoic acids for characterization of cellular retinoic acid-binding proteins I and II

      PROTEIN SCIENCE
    33. Cok, I; Kocabas, NA; Cholerton, S; Karakaya, AE; Sardas, S
      Determination of coumarin metabolism in Turkish population

      HUMAN & EXPERIMENTAL TOXICOLOGY
    34. Hoffman, SMG; Nelson, DR; Keeney, DS
      Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19

      PHARMACOGENETICS
    35. Dai, D; Zeldin, DC; Blaisdell, JA; Chanas, B; Coulter, SJ; Ghanayem, BI; Goldstein, JA
      Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid

      PHARMACOGENETICS
    36. Tang, CY; Shou, MG; Rushmore, TH; Mei, Q; Sandhu, P; Woolf, EJ; Rose, MJ; Gelmann, A; Greenberg, HE; De Lepeleire, I; Van Hecken, A; De Schepper, PJ; Ebel, DL; Schwartz, JI; Rodrigues, AD
      In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelicvariant forms of human liver microsomal cytochrome P4502C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics

      PHARMACOGENETICS
    37. Gervasini, G; Martinez, C; Agundez, JAG; Garcia-Gamito, FJ; Benitez, J
      Inhibition of cytochrome P4502C9 activity in vitro by 5-hydroxytryptamine and adrenaline

      PHARMACOGENETICS
    38. Boger, RH
      Drug interactions of them statins and consequences for drug selection

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    39. Navarro-Antolin, J; Lamas, S
      Nitrosative stress by cyclosporin A in the endothelium: studies with the NO-sensitive probe diaminofluorescein-2/diacetate using flow cytometry

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    40. Kovacic, P; Jacintho, JD
      Mechanisms of carcinogenesis: Focus on oxidative stress and electron transfer

      CURRENT MEDICINAL CHEMISTRY
    41. Brosen, K; Naranjo, CA
      Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    42. Kosel, M; Amey, M; Aubert, AC; Baumann, P
      In vitro metabolism of citalopram by monoamine oxidase B in human blood

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    43. Sekine, I; Saijo, N
      Polymorphisms of metabolizing enzymes and transporter proteins involved inthe clearance of anticancer agents

      ANNALS OF ONCOLOGY
    44. Nelson, MH; Birnbaum, AK; Remmel, RP
      Inhibition of phenytoin hydroxylation in human liver microsomes by severalselective serotonin re-uptake inhibitors

      EPILEPSY RESEARCH
    45. Narimatsu, S; Arai, T; Masubuchi, Y; Horie, T; Hosokawa, M; Ueno, K; Kataoka, H; Yamamoto, S; Ishikawa, T; Cho, AK
      Inactivation of rat cytochrome P450 2D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    46. Asano, T; Kushida, H; Sadakane, C; Ishihara, K; Wakui, Y; Yanagisawa, T; Kimura, M; Kamei, H; Yoshida, T
      Metabolism of ipecac alkaloids cephaeline and emetine by human hepatic microsomal cytochrome P450s, and their inhibitory effects on P450 enzyme activities

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    47. Soyama, A; Saito, Y; Hanioka, N; Murayama, N; Nakajima, O; Katori, N; Ishida, S; Sai, K; Ozawa, S; Sawada, J
      Non-synonymous single nucleotide alterations found in the CYP2C8 gene result in reduced in vitro paclitaxel metabolism

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    48. Murayama, N; Sai, K; Nakajima, Y; Kaniwa, N; Ozawa, S; Ohno, Y; Sawada, J
      Expression of CYP2A6 in turner cells augments cellular sensitivity to tegafur

      JAPANESE JOURNAL OF CANCER RESEARCH
    49. Jokinen, MJ; Ahonen, J; Neuvonen, PJ; Olkkola, KT
      Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine

      PHARMACOLOGY & TOXICOLOGY
    50. Guengerich, FP
      Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity

      CHEMICAL RESEARCH IN TOXICOLOGY
    51. Lowry, JA; Corry, A; Fitzmaurice, L; Jackson, MA; Kearns, GL
      Coadministration of mefloquine and chloroquine: Use of a pharmacokinetic-based approach to reduce toxicity

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    52. Yoshitomi, S; Ikemoto, K; Takahashi, J; Miki, H; Namba, M; Asahi, S
      Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology

      TOXICOLOGY IN VITRO
    53. Bhoopathy, S; Sarkar, M; Karnes, HT
      A direct injection capillary electrophoretic technique for miniaturized high-throughput metabolic screening of the CYP 3A4 enzyme using quinidine as a probe

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    54. Piver, B; Berthou, F; Dreano, Y; Lucas, D
      Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components

      TOXICOLOGY LETTERS
    55. Sorbera, LA; Revel, L; Martin, L; Castaner, J
      Escitalopram oxalate - Antidepressant - 5-HT reuptake inhibitor

      DRUGS OF THE FUTURE
    56. Meskar, A; Plee-Gautier, E; Amet, Y; Berthou, F; Lucas, D
      Alcohol-xenobiotics interactions. Role of cytochrome P450 2E1.

      PATHOLOGIE BIOLOGIE
    57. Guemei, AA; Cottrell, J; Band, R; Hehman, H; Prudhomme, M; Pavlov, MV; Grem, JL; Ismail, AS; Bowen, D; Taylor, RE; Takimoto, CH
      Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    58. Bonnabry, P; Sievering, J; Leemann, T; Dayer, P
      Quantitative drug interactions prediction system (Q-DIPS) - A dynamic computer-based method to assist in the choice of clinically relevant in vivo studies

      CLINICAL PHARMACOKINETICS
    59. Takahashi, H; Echizen, H
      Pharmacogenetics of warfarin elimination and its clinical implications

      CLINICAL PHARMACOKINETICS
    60. Andersson, T; Hassan-Alin, M; Hasselgren, G; Rohss, K
      Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole

      CLINICAL PHARMACOKINETICS
    61. Giao, PT; de Vries, PJ
      Pharmacokinetic interactions of antimalarial agents

      CLINICAL PHARMACOKINETICS
    62. Ensom, MHH; Chang, TKH; Patel, P
      Pharmacogenetics - The therapeutic drug monitoring of the future?

      CLINICAL PHARMACOKINETICS
    63. Pea, F; Furlanut, M
      Pharmacokinetic aspects of treating infections in the intensive care unit - Focus on drug interactions

      CLINICAL PHARMACOKINETICS
    64. Kerbusch, T; de Kraker, J; Keizer, HJ; van Putten, JWG; Groen, HJM; Jansen, RLH; Schellens, JHM; Beijnen, JH
      Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites

      CLINICAL PHARMACOKINETICS
    65. Wen, X; Wang, JS; Kivisto, KT; Neuvonen, PJ; Backman, JT
      In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P4502C9 (CYP2C9)

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    66. Raunio, H; Rautio, A; Gullsten, H; Pelkonen, O
      Polymorphisms of CYP2A6 and its practical consequences

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    67. Zhou, SF; Chin, R; Kestell, P; Tingle, MD; Paxton, JW
      Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    68. Bournique, B; Lambert, N; Boukaiba, R; Martinet, M
      In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine 1-carboxamide)

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    69. Senda, C; Yamaura, Y; Kobayashi, K; Fujii, H; Minami, H; Sasaki, Y; Igarashi, T; Chiba, K
      Influence of the CYP2D6*10 allele on the metabolism of mexiletine by humanliver microsomes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    70. Boulton, DW; Arnaud, P; DeVane, CL
      A single dose of methadone inhibits cytochrome P-4503A activity in healthyvolunteers as assessed by the urinary cortisol ratio

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    71. Hyland, R; Roe, EGH; Jones, BC; Smith, DA
      Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    72. Matsumoto, S; Yamazoe, Y
      Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    73. Shin, JG; Kane, K; Flockhart, DA
      Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    74. Benowitz, NL; Jacob, P
      Trans-3 '-hydroxycotinine: Disposition kinetics, effects and plasma levelsduring cigarette smoking

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    75. Paschke, T; Riefler, M; Schuler-Metz, A; Wolz, L; Scherer, G; McBride, CM; Bepler, G
      Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method

      TOXICOLOGY
    76. Walton, K; Dorne, JL; Renwick, AG
      Uncertainty factors for chemical risk assessment: interspecies differencesin the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates

      FOOD AND CHEMICAL TOXICOLOGY
    77. Dorne, JLCM; Walton, K; Renwick, AG
      Uncertainty factors for chemical risk assessment: human variability in thepharmacokinetics of CYP1A2 probe substrates

      FOOD AND CHEMICAL TOXICOLOGY
    78. Teyssier, C; Amiot, MJ; Mondy, N; Auger, J; Kahane, R; Siess, MH
      Effect of onion consumption by rats on hepatic drug-metabolizing enzymes

      FOOD AND CHEMICAL TOXICOLOGY
    79. Gutierrez, M; Abramowitz, W
      Lack of effect of a single dose of ketoconazole on the pharmacokinetics ofcitalopram

      PHARMACOTHERAPY
    80. Redman, AR
      Implications of cytochrome P4502C9 polymorphism on Warfarin metabolism anddosing

      PHARMACOTHERAPY
    81. Liston, HL; Markowitz, JS; DeVane, CL
      Drug glucuronidation in clinical psychopharmacology

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    82. Hartter, S; Wang, XM; Weigmann, H; Friedberg, T; Arand, M; Oesch, F; Hiemke, C
      Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    83. Eap, CB; Broly, F; Mino, A; Hammig, R; Deglon, JJ; Uehlinger, C; Meili, D; Chevalley, AF; Bertschy, G; Zullino, D; Kosel, M; Preisig, M; Baumann, P
      Cytochrome P450 2D6 genotype and methadone steady-state concentrations

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    84. Mori, Y; Koide, A; Fuwa, K; Kobayashi, Y
      N-Benzylimidazole for preparation of S9 fraction with multi-induction of metabolizing enzymes in short-term genotoxicity assays

      MUTAGENESIS
    85. Kumar, GN; Surapaneni, S
      Role of drug metabolism in drug discovery and development

      MEDICINAL RESEARCH REVIEWS
    86. Agoram, B; Woltosz, WS; Bolger, MB
      Predicting the impact of physiological and biochemical processes on oral drug bioavailability

      ADVANCED DRUG DELIVERY REVIEWS
    87. Wacher, VJ; Salphati, L; Benet, LZ
      Active secretion and enterocytic drug metabolism barriers to drug absorption

      ADVANCED DRUG DELIVERY REVIEWS
    88. Iscan, M; Klaavuniemi, T; Coban, T; Kapucuoglu, N; Pelkonen, O; Raunio, H
      The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue

      BREAST CANCER RESEARCH AND TREATMENT
    89. Cho, US; Ahn, HJ; Park, EY; Dong, MS; Kim, KH
      Influence of ligand binding to human cytochrome P-450 1A2: conformational activation and stabilization by alpha-naphthoflavone

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    90. Carlsson, B; Olsson, G; Reis, M; Walinder, J; Nordin, C; Lundmark, J; Scordo, MG; Dahl, ML; Bengtsson, F; Ahlner, J
      Enantioselective analysis of citalopram and metabolites in adolescents

      THERAPEUTIC DRUG MONITORING
    91. Spina, E; Avenoso, A; Facciola, G; Scordo, MG; Ancione, M; Madia, A
      Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine

      THERAPEUTIC DRUG MONITORING
    92. Lundmark, J; Reis, M; Bengtsson, F
      Serum concentrations of fluoxetine in the clinical treatment setting

      THERAPEUTIC DRUG MONITORING
    93. Phillips, DH
      Understanding the genotoxicity of tamoxifen?

      CARCINOGENESIS
    94. Yueh, MF; Nguyen, N; Famourzadeh, M; Strassburg, CP; Oda, Y; Guengerich, FP; Tukey, RH
      The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines

      CARCINOGENESIS
    95. Nan, HM; Kim, N; Lim, HS; Choi, JK; Kawamoto, T; Kang, JW; Lee, CH; Kim, YD; Kwon, FH
      Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations

      CARCINOGENESIS
    96. Hirota, N; Ito, K; Iwatsubo, T; Green, CE; Tyson, CA; Shimada, N; Suzuki, H; Sugiyama, Y
      In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans

      BIOPHARMACEUTICS & DRUG DISPOSITION
    97. Khalil, WF; Saitoh, T; Shimoda, M; Kokue, E
      In vitro cytochrome P450-mediated hepatic activities for five substrates in specific pathogen free chickens

      JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS
    98. Gill, J; Feinberg, J
      Saquinavir soft gelatin capsule - A comparative safety review

      DRUG SAFETY
    99. Olesen, OV; Linnet, K
      Contributions of five human cytochrome P450 isoforms to the N-demethylation of clozapine in vitro at low and high concentrations

      JOURNAL OF CLINICAL PHARMACOLOGY
    100. Kim, JS; Nafziger, AN; Gaedigk, A; Dickmann, LJ; Rettie, AE; Bertino, JS
      Effects of oral vitamin K on S- and R-Warfarin pharmacokinetics and pharmacodynamics: Enhanced safety of warfarin as a CYP2C9 probe

      JOURNAL OF CLINICAL PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 12:10:24